Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enersense International | 42U | Nov 22, 2024 | 2.19 | -1.35 |
Enerside Energy S.A. | 9O8 | Nov 22, 2024 | 3.90 | +1.04 |
Enersize | 9H0 | Nov 22, 2024 | 0.00 | -50.00 |
EnerSys | FDN | Nov 22, 2024 | 93.25 | +3.27 |
Enertime | E0T | Nov 22, 2024 | 0.15 | 0.00 |
Engcon AB | 917 | Nov 22, 2024 | 9.65 | +3.99 |
Enghouse Systems Ltd | 3E4 | Nov 22, 2024 | 19.90 | +1.02 |
Engie | GZFB | Nov 22, 2024 | 15.30 | 0.00 |
Engie Brasil Energia S A American Depositary Receipts - Spon | 7TE1 | Nov 22, 2024 | 5.75 | -3.36 |
Engie EPS | 8XE | Nov 22, 2024 | 1.20 | 0.00 |
Engie SA | GZF | Nov 22, 2024 | 15.46 | +0.23 |
Engineer Gold Mines Ltd | 9EG0 | Nov 22, 2024 | 0.02 | -15.38 |
Enhabit | X34 | Nov 22, 2024 | 7.00 | +0.72 |
Eni ADR | ENI1 | Nov 22, 2024 | 27.20 | +0.74 |
Eni SpA | ENI | Nov 22, 2024 | 13.89 | +1.02 |
Eniro | EN8A | Nov 22, 2024 | 0.03 | +2.17 |
ENKA INSAAT (U.ADR)/4 TN1 | ENP | Nov 22, 2024 | 4.82 | +0.42 |
Enlivex Therapeutics Ltd. - Ordinary Shares | 1BT | Nov 22, 2024 | 0.79 | -13.19 |
ENN ENERGY | XGH | Nov 22, 2024 | 6.10 | -1.61 |
ENN ENERGY HLD.UNS.ADR/25 | XGH0 | Nov 22, 2024 | 24.20 | -1.63 |
ENNOGIE SOL.GRP. NAM. DK1 | B0W | Nov 22, 2024 | 0.88 | +1.39 |
Enochian Biosciences Inc | 2Q5 | Nov 22, 2024 | 0.44 | -4.06 |
Enogia S.A | 7BZ | Nov 22, 2024 | 1.50 | -1.32 |
Enova International, Inc. | 27E | Nov 22, 2024 | 94.50 | +3.28 |
ENOVIS CORP. | C520 | Nov 22, 2024 | 44.00 | +3.77 |
Enphase Energy, Inc. | E0P | Nov 22, 2024 | 62.76 | +2.17 |
EnPro Industries Inc | EP9 | Nov 22, 2024 | 176.00 | +2.92 |
EnQuest PLC | 3EQ | Nov 22, 2024 | 0.14 | -0.87 |
ENRG ELEMENTS LTD. | O9B | Nov 22, 2024 | 0.00 | 0.00 |
Enstar Group Limited - Ordinary Shares | 48R | Nov 22, 2024 | 300.00 | +0.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.